1-10 of 10
Korean Multiple Myeloma Working Party
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical Efficacy of a Bortezomib, Cyclophosphamide and Dexamethasone Compared with Bortezomib, Cyclophosphamide, Thalidomide and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma

Jae-Sook Ahn, MD, PhD, Deok-Hwan Yang, MD, PhD, Joon Ho Moon, MD, PhD, Sang Kyun Sohn, MD, PhD, Sung-Hoon Jung, MD, Soo-Young Bae, MD, Yeo-Kyeoung Kim, MD, PhD, Hyeoung-Joon Kim, Je-Jung Lee, MD, PhD, The Korean Multiple Myeloma Working Party KMMWP
Journal: Blood
Blood (2011) 118 (21): 1868.
https://doi.org/10.1182/blood.V118.21.1868.1868
Published: 2011
Journal Articles

Myelomatous Pleural Effusion of Multiple Myeloma: Characteristics and Outcome.

Hyo Jung Kim, M.D., Ph.D., Dae Ro Choi, M.D., Gak-Won Yun, M.D., Eunkyung Park, M.D., Ph.D., Seok Jin Kim, MD, PhD, Young Kyung Lee, M.D., Ph.D., Jong-Ho Won, M.D., Ph.D., Sung-Soo Yoon, M.D., Ph.D., Cheolwon Suh, M.D., Ph.D., Korean Multiple Myeloma Working Party, (KMMWP)
Journal: Blood
Blood (2009) 114 (22): 3874.
https://doi.org/10.1182/blood.V114.22.3874.3874
Published: 2009
Journal Articles

Osteonecrosis of the Jaw in Multiple Myeloma Patients: Incidence and Characteristics in Korean Patients.

Hyo Jung Kim, M.D., Ph.D., Hyeok Shim, M.D., Eunkyung Park, M.D., Ph.D., Min Kyoung Kim, M.D., Seok Jin Kim, MD, PhD, Joon Seong Park, M.D., Ph.D., Jong-Ho Won, M.D., Ph.D., Chang-Ki Min, M.D., Ph.D., Jae Hoon Lee, M.D., Ph.D., Korean Multiple Myeloma Working Party, (KMMWP)
Journal: Blood
Blood (2009) 114 (22): 4956.
https://doi.org/10.1182/blood.V114.22.4956.4956
Published: 2009
Journal Articles

The Prognostic Impact of Fluorescent-in Situ Hybridization (FISH) and Conventional Karyotying in Korean Multiple Myeloma Patients: A Retrospective Multicenter Study.

Min Jae Kim, Suk Joong Oh, Chang Ki Min, Chong Won Park, Hwi-Joong Yoon, Young Rok Do, Byung Soo Kim, Yang Soo Kim, Hyeon Seok Eom, Hun-Mo Ryoo, Sung Hyun Kim, Ho Jin Shin, Soo-Mee Bang, Seok Jin Kim, Sung-Soo Yoon, Dong Soon Lee, Cheolwon Suh, Jin Seok Kim, Jong Ho Won, Seongkyu Park, Min Kyoung Kim, Hyeok Shim, Hye Jin Kang, Chul Soo Kim, Je-Jung Lee, Jae-Yong Kwak, Deog Yeon Jo, Jae Hoon Lee, Korean Multiple Myeloma Working Party
Journal: Blood
Blood (2009) 114 (22): 4902.
https://doi.org/10.1182/blood.V114.22.4902.4902
Published: 2009
Journal Articles

Clinical Efficacy of VEL-CTD (Bortezomib, Cyclophosphamide, Thalidomide, and Dexamethasone) Regimen in Patients with Relapsed or Refractory Multiple Myeloma: A Phase II Study

Yeo-Kyeoung Kim, Je-Jung Lee, Sang-Kyun Sohn, Ho-Jin Shin, Joo-Seop Chung, Young-Jin Choi, Joon-Ho Moon, Yee-Soo Chae, Jong-Gwang Kim, Jae-Sook Ahn, Deok-Hwan Yang, Hyeoung-Joon Kim, the Korean Multiple Myeloma Working Party (KMMWP)
Journal: Blood
Blood (2008) 112 (11): 3693.
https://doi.org/10.1182/blood.V112.11.3693.3693
Published: 2008
Journal Articles

Low Incidence of Thromboembolism in Asian Multiple Myeloma Patients Treated with Thalidomide: Do We Really Need Prophylaxis for Thromboembolism in Asian Population?

Youngil Koh, Soo-Mee Bang, MD, PhD, Jae Hoon Lee, Hwi-Joong Yoon, Young-Rok Do, PhD, Hun-Mo Ryoo, Nari Lee, Seok Jin Kim, MD, PhD, Sung-Soo Yoon, MD, PhD, Jong-Ho Won, MD, PhD, Yeung-Chul Mun, MD, PhD, Moon-Hee Lee, Jong-Youl Jin, MD, PhD, Hyo-Jung Kim, HyeonSeok Eom, MD, PhD, Min Kyoung Kim, MD, Hyun Chun Shin, Korean Multiple Myeloma Working Party
Journal: Blood
Blood (2008) 112 (11): 5146.
https://doi.org/10.1182/blood.V112.11.5146.5146
Published: 2008
Journal Articles

Methylation Profiles of p16, p15 and p14 Genes in Korean Patients with Multiple Myeloma.

Seong-Ho Kang, MD, Dong Soon Lee, MD, PhD, Tae Young Kim, Hyun Jung Min, Bo Ra Oh, Han-Ik Cho, MD, PhD, Sung-Soo Yoon, MD, PhD, the Korean Multiple Myeloma Working Party
Journal: Blood
Blood (2007) 110 (11): 1504.
https://doi.org/10.1182/blood.V110.11.1504.1504
Published: 2007
Journal Articles

Varicella Zoster Virus Reactivation with the Use of Bortezomib in Relapsed or Refractory Multiple Myeloma Patients.

Seok Jin Kim, Hyo-Jin Lee, Hawk Kim, Kihyun Kim, Jae-Yong Kwak, Seung-Hyun Nam, Jung Hye Kwon, Sang Kyun Sohn, Jong-Ho Won, Jae Hoon Lee, Cheolwon Suh, Sung-Soo Yoon, Yongjun Cha, Hye Jin Kim, Inho Kim, Young-Rok Do, Won-Sik Lee, Young-Don Joo, Hyo Jung Kim, the Korean Multiple Myeloma Working Party (KMMWP)
Journal: Blood
Blood (2007) 110 (11): 4843.
https://doi.org/10.1182/blood.V110.11.4843.4843
Published: 2007
Journal Articles

(−)-Epigallocatechin-3-Gallate (EGCG), Green Tea Component, Antagonize the Anti-Myeloma Activity of Proteasome Inhibitor PS-341 by Direct Chemical Interaction.

Tae Young Kim, MS, Jongmin Park, BS, Bora Oh, MS, Hyun Jung Min, BS, Tae-Sook Jeong, PhD, Jae Hoon Lee, MD, PhD, Seung Bum Park, PhD, Dong Soon Lee, MD, PhD, the Korean Multiple Myeloma Working Party (KMMWP)
Journal: Blood
Blood (2007) 110 (11): 4850.
https://doi.org/10.1182/blood.V110.11.4850.4850
Published: 2007
Journal Articles

Complete Remission Status at Autologous Transplantation Is an Important Prognostic Factor in Multiple Myeloma Patients Received Upfront Single Autologous Transplantation.

Jin Seok Kim, MD, June-Won Cheong, MD, Yoo-Hong Min, MD, Cheolwon Suh, ND, Hawk Kim, MD, Deog Yeon Jo, MD, Hun Mo Ryoo, MD, Kihyun Kim, MD, Sung Soo Yoon, MD, Jae Hoon Lee, MD, the Korean Multiple Myeloma Working Party (KMMWP)
Journal: Blood
Blood (2007) 110 (11): 955.
https://doi.org/10.1182/blood.V110.11.955.955
Published: 2007